The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomas, S.
Right arrow Articles by Brumeanu, T.-D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomas, S.
Right arrow Articles by Brumeanu, T.-D.
The Journal of Immunology, 2003, 170: 5981-5992.
Copyright © 2003 by The American Association of Immunologists

A Model for Antigen-Specific T-Cell Anergy: Displacement of CD4-p56lck Signalosome from the Lipid Rafts by a Soluble, Dimeric Peptide-MHC Class II Chimera1

Sunil Thomas, Rajeev Kumar, Anca Preda-Pais, Sofia Casares and Teodor-D. Brumeanu2

Department of Microbiology, Mount Sinai School of Medicine, New York, NY 10029

Soluble, dimeric peptide-MHC chimeras were shown to induce Ag-specific T cell anergy in vitro and in vivo. In this study, we describe a mechanism by which a soluble, dimeric peptide MHC class II chimera (DEF) induces Ag-specific T cell anergy. The anergic cells showed a displacement of the CD4-p56lck signaling module from the GM1-rich plasma membrane microdomains (lipid rafts), and subsequently an increase in p59fyn kinase activity, a dominant expression of p21 inhibitory TCR {zeta}-chain, and a poor phosphorylation and recruitment of {zeta}-associated protein of 70 kDa kinase to the TCR’s immunoreceptor tyrosine-based activation motifs. The Th1 and Th2 transcription was suppressed and the cells were arrested in the Th0 stage of differentiation. Recovery from DEF anergy occurred late and spontaneously at the expense of low thresholds for activation-induced cell death. In contrast to DEF, a combination of TCR and CD4 mAbs did not induce such alterations or anergy, indicating that the ligand-mediated topology of TCR and CD4 coengagement can differentially affect the T cell function. Our results argue for a model of anergy in which the defective partitioning of signaling molecules in lipid rafts is an early, negative signaling event in T cells. Physiological ligands like DEF chimeras may provide new tools for silencing the autoimmune processes, and may also help in deciphering new mechanisms of negative regulation in T cells.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. M. Morton, B. McManus, P. Garside, A. McI. Mowat, and M. M. Harnett
Inverse Rap1 and Phospho-ERK Expression Discriminate the Maintenance Phase of Tolerance and Priming of Antigen-Specific CD4+ T Cells In Vitro and In Vivo
J. Immunol., December 15, 2007; 179(12): 8026 - 8034.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Kreijveld, H. J. P. M. Koenen, L. B. Hilbrands, H. J. P. van Hooff, and I. Joosten
The immunosuppressive drug FK778 induces regulatory activity in stimulated human CD4+CD25- T cells
Blood, January 1, 2007; 109(1): 244 - 252.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. C. J. Fawcett and U. Lorenz
Localization of Src Homology 2 Domain-Containing Phosphatase 1 (SHP-1) to Lipid Rafts in T Lymphocytes: Functional Implications and a Role for the SHP-1 Carboxyl Terminus
J. Immunol., March 1, 2005; 174(5): 2849 - 2859.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Andris, S. Denanglaire, F. de Mattia, J. Urbain, and O. Leo
Naive T Cells Are Resistant to Anergy Induction by Anti-CD3 Antibodies
J. Immunol., September 1, 2004; 173(5): 3201 - 3208.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.